CVS Pharmacy
Retail pharmacy with declining footfall and brutal UX
Some genuine powers in play. Disruption needs more than better tech — it needs a real angle.
What they do
CVS operates ~9,000 retail pharmacies. The in-store experience is consistently rated poorly; pharmacists are overworked; prescription pickup is friction-heavy. Mail-order and Mark Cuban's Cost Plus Drugs are siphoning script volume.
Why they're disruptable
A direct-to-consumer pharmacy that uses telehealth + same-day delivery + transparent cash pricing can serve the 40% of Americans who pay out-of-pocket for at least one prescription.
7 Powers defensibility
Hamilton Helmer's framework. Higher score = harder to disrupt on that axis.
Multiple compounding powers. Frontal attack will fail; look for counter-positioning openings.
- Scale EconomiesPer-unit cost decreases as volume grows. Big players' fixed costs amortize across more output.5/5
The Aetna acquisition gave them payer + pharmacy + PBM vertical scale; per-script economics are very strong.
- Network EconomiesThe product gets more valuable as more people use it. Each new user benefits the existing ones.2/5
Pharmacy network density helps but doesn't compound.
- Counter-PositioningA business model competitors can't copy without damaging their existing business (e.g. cannibalization).2/5
Vertical integration with Aetna is hard for pure-play retail challengers to copy.
- Switching CostsThe pain — financial, procedural, emotional — a customer faces to move to an alternative.3/5
Most people stick with their pharmacy out of inertia, but switching is procedurally easy.
- BrandingCustomers pay more or choose by default because of identity, trust, or affective association.3/5
Recognized but not loved; 'CVS' doesn't carry positive sentiment.
- Cornered ResourcePreferential access to a coveted asset — talent, IP, contracts, real estate, regulatory permits.4/5
9,000+ retail locations within 5 miles of 70% of Americans; the physical footprint is hard to replicate.
- Process PowerEmbedded organizational processes and culture competitors can't replicate quickly (e.g. Toyota Production System).3/5
Pharmacy operations under significant strain; ongoing staffing crisis at the store level.
Discussion (0)
Make the case for or against the disruption thesis.